Pan Coronavirus Genomic Surveillance of a Large NHP Colony

大型 NHP 群体的泛冠状病毒基因组监测

基本信息

  • 批准号:
    10575848
  • 负责人:
  • 金额:
    $ 8.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-11-14 至 2024-10-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract The novel coronavirus that emerged in late 2019, termed SARS-CoV-2, quickly spread throughout the world and has killed millions. A critical aspect of this pandemic that remains understudied is the impact of immunity to seasonal coronaviruses on COVID-19 disease. Several lines of evidence suggest there is an impact but the nature of that impact remains unclear. We have preliminary data confirming our colony of 5,000 rhesus macaques harbors a large fraction of animals with preexisting immunity to coronaviruses of unknown origin. This immunity may be important in the use of these animals for COVID-19 and other coronavirus disease. We hypothesize that our colony seasonally circulates human seasonal coronaviruses but we need to identify the actual viruses circulating. Here, we will use multiple approaches to assess the frequency of these infections and to identify the actual viruses. In Aim 1, we will use pan-coronavirus primers to quantify coronavirus infections in our colony. We will sample both nasal and rectal sites as coronaviruses are known to be shed from both. In Aim 2, we will use next generation sequencing to identify the viruses circulating. We will apply phylogenetic approaches to characterize the diversity of the virus or viruses in our colony. These data will have important implications for the use of macaques for coronavirus infections in general and may shed light on the coronavirus family.
项目总结/文摘

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nicholas James Maness其他文献

Nicholas James Maness的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nicholas James Maness', 18)}}的其他基金

T cell modulation of COVID-19 disease
COVID-19 疾病的 T 细胞调节
  • 批准号:
    10674085
  • 财政年份:
    2021
  • 资助金额:
    $ 8.75万
  • 项目类别:
T cell modulation of COVID-19 disease
COVID-19 疾病的 T 细胞调节
  • 批准号:
    10239822
  • 财政年份:
    2021
  • 资助金额:
    $ 8.75万
  • 项目类别:
T cell modulation of COVID-19 disease
COVID-19 疾病的 T 细胞调节
  • 批准号:
    10491340
  • 财政年份:
    2021
  • 资助金额:
    $ 8.75万
  • 项目类别:
Reservoir modulation by Nef and anti-nef CTL
Nef 和抗 nef CTL 对储层的调节
  • 批准号:
    9927138
  • 财政年份:
    2020
  • 资助金额:
    $ 8.75万
  • 项目类别:
Reservoir modulation by Nef and anti-nef CTL
Nef 和抗 nef CTL 对储层的调节
  • 批准号:
    10261352
  • 财政年份:
    2020
  • 资助金额:
    $ 8.75万
  • 项目类别:
Focused characterization of non-canonical T cells against SIV
针对 SIV 的非典型 T 细胞的重点表征
  • 批准号:
    9560521
  • 财政年份:
    2018
  • 资助金额:
    $ 8.75万
  • 项目类别:
SIV antisense epitopes as novel markers of latency
SIV 反义表位作为新的潜伏期标记
  • 批准号:
    8846907
  • 财政年份:
    2015
  • 资助金额:
    $ 8.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了